Epoch Investment Partners Inc. decreased its holdings in shares of Henry Schein, Inc. (NASDAQ:HSIC) by 11.5% during the 4th quarter, Holdings Channel reports. The firm owned 78,609 shares of the company’s stock after selling 10,189 shares during the period. Epoch Investment Partners Inc.’s holdings in Henry Schein were worth $6,173,000 as of its most recent SEC filing.
Several other institutional investors and hedge funds have also made changes to their positions in the company. Financial Gravity Companies Inc. bought a new stake in shares of Henry Schein during the 4th quarter worth $29,000. Bruderman Asset Management LLC bought a new stake in shares of Henry Schein during the 4th quarter worth $39,000. Ipswich Investment Management Co. Inc. bought a new stake in shares of Henry Schein during the 4th quarter worth $45,000. Howe & Rusling Inc. boosted its holdings in shares of Henry Schein by 200.0% during the 4th quarter. Howe & Rusling Inc. now owns 600 shares of the company’s stock worth $47,000 after buying an additional 400 shares during the period. Finally, Essex Savings Bank bought a new stake in shares of Henry Schein during the 4th quarter worth $48,000.
In other Henry Schein news, Director Philip A. Laskawy sold 1,084 shares of the stock in a transaction on Tuesday, March 12th. The shares were sold at an average price of $59.86, for a total value of $64,888.24. Following the completion of the sale, the director now directly owns 32,899 shares of the company’s stock, valued at approximately $1,969,334.14. The sale was disclosed in a legal filing with the SEC, which is available through the SEC website. 1.15% of the stock is owned by corporate insiders.
Several research firms recently issued reports on HSIC. Piper Jaffray Companies reaffirmed an “overweight” rating and set a $96.00 price objective on shares of Henry Schein in a report on Thursday, November 29th. Zacks Investment Research downgraded shares of Henry Schein from a “hold” rating to a “sell” rating in a report on Wednesday, February 6th. BidaskClub raised shares of Henry Schein from a “sell” rating to a “hold” rating in a report on Thursday, February 7th. UBS Group began coverage on shares of Henry Schein in a report on Thursday, January 17th. They set a “sell” rating and a $73.00 price objective for the company. Finally, Robert W. Baird downgraded shares of Henry Schein from an “outperform” rating to a “neutral” rating and set a $76.60 price objective for the company. in a report on Wednesday, January 2nd. Seven investment analysts have rated the stock with a sell rating, six have given a hold rating and six have issued a buy rating to the stock. The company currently has an average rating of “Hold” and a consensus price target of $79.87.
Shares of Henry Schein stock opened at $59.10 on Friday. The company has a quick ratio of 0.68, a current ratio of 1.30 and a debt-to-equity ratio of 0.28. Henry Schein, Inc. has a fifty-two week low of $56.58 and a fifty-two week high of $91.35. The firm has a market capitalization of $9.06 billion, a price-to-earnings ratio of 14.31, a P/E/G ratio of 2.22 and a beta of 0.88.
Henry Schein (NASDAQ:HSIC) last issued its quarterly earnings results on Wednesday, February 20th. The company reported $1.12 earnings per share for the quarter, beating analysts’ consensus estimates of $1.11 by $0.01. Henry Schein had a net margin of 4.06% and a return on equity of 19.86%. The firm had revenue of $3.38 billion during the quarter, compared to the consensus estimate of $3.46 billion. During the same period in the prior year, the firm earned $0.97 EPS. The business’s revenue was up 1.7% on a year-over-year basis. On average, equities research analysts expect that Henry Schein, Inc. will post 3.44 earnings per share for the current fiscal year.
Henry Schein declared that its Board of Directors has initiated a share repurchase plan on Thursday, December 13th that allows the company to repurchase $400.00 million in shares. This repurchase authorization allows the company to reacquire up to 3.1% of its stock through open market purchases. Stock repurchase plans are generally an indication that the company’s board believes its stock is undervalued.
WARNING: This piece was originally reported by Transcript Daily and is the sole property of of Transcript Daily. If you are accessing this piece on another domain, it was stolen and republished in violation of US & international trademark and copyright law. The legal version of this piece can be read at https://transcriptdaily.com/2019/03/15/epoch-investment-partners-inc-has-6-17-million-stake-in-henry-schein-inc-hsic.html.
Henry Schein Profile
Henry Schein, Inc provides health care products and services to dental practitioners and laboratories, physician practices, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services.
Further Reading: Backdoor Roth IRA Conversion and Strategy
Want to see what other hedge funds are holding HSIC? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Henry Schein, Inc. (NASDAQ:HSIC).
Receive News & Ratings for Henry Schein Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Henry Schein and related companies with MarketBeat.com's FREE daily email newsletter.